IceCure Medical Statistics

Total Valuation

ICCM has a market cap or net worth of $61.35 million. The enterprise value is $51.17 million.

Market Cap	61.35M
Enterprise Value	51.17M

Important Dates

The last earnings date was Tuesday, November 26, 2024, before market open.

Earnings Date	Nov 26, 2024
Ex-Dividend Date	n/a

Share Statistics

ICCM has 54.78 million shares outstanding. The number of shares has increased by 10.71% in one year.

Current Share Class	54.78M
Shares Outstanding	54.78M
Shares Change (YoY)	+10.71%
Shares Change (QoQ)	+5.79%
Owned by Insiders (%)	50.13%
Owned by Institutions (%)	0.38%
Float	27.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.73
Forward PS	12.74
PB Ratio	6.10
P/TBV Ratio	6.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	13.94
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.05.

Current Ratio	2.67
Quick Ratio	2.16
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -111.35% and return on invested capital (ROIC) is -70.31%.

Return on Equity (ROE)	-111.35%
Return on Assets (ROA)	-52.54%
Return on Capital (ROIC)	-70.31%
Revenue Per Employee	$47,675
Profits Per Employee	-$179,662
Employee Count	77
Asset Turnover	0.21
Inventory Turnover	0.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.61% in the last 52 weeks. The beta is 2.61, so ICCM's price volatility has been higher than the market average.

Beta (5Y)	2.61
52-Week Price Change	+18.61%
50-Day Moving Average	0.75
200-Day Moving Average	0.85
Relative Strength Index (RSI)	75.26
Average Volume (20 Days)	646,373

Short Selling Information

The latest short interest is 1.47 million, so 2.68% of the outstanding shares have been sold short.

Short Interest	1.47M
Short Previous Month	2.31M
Short % of Shares Out	2.68%
Short % of Float	5.38%
Short Ratio (days to cover)	0.46

Income Statement

In the last 12 months, ICCM had revenue of $3.67 million and -$13.83 million in losses. Loss per share was -$0.29.

Revenue	3.67M
Gross Profit	1.60M
Operating Income	-14.59M
Pretax Income	-14.49M
Net Income	-13.83M
EBITDA	-14.25M
EBIT	-14.59M
Loss Per Share	-$0.29

Full Income Statement

Balance Sheet

The company has $10.67 million in cash and $486,000 in debt, giving a net cash position of $10.19 million or $0.19 per share.

Cash & Cash Equivalents	10.67M
Total Debt	486,000
Net Cash	10.19M
Net Cash Per Share	$0.19
Equity (Book Value)	10.06M
Book Value Per Share	0.18
Working Capital	8.34M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$10.64 million and capital expenditures -$147,000, giving a free cash flow of -$10.79 million.

Operating Cash Flow	-10.64M
Capital Expenditures	-147,000
Free Cash Flow	-10.79M
FCF Per Share	-$0.20

Full Cash Flow Statement

Margins

Gross Margin	43.67%
Operating Margin	-397.33%
Pretax Margin	-376.85%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ICCM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.71%
Shareholder Yield	-10.71%
Earnings Yield	-22.55%
FCF Yield	-17.59%

Analyst Forecast

The average price target for ICCM is $2.70, which is 141.07% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.70
Price Target Difference	141.07%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	81.79%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ICCM has an Altman Z-Score of -6.29 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.29
Piotroski F-Score	3